| Literature DB >> 26380421 |
Dilek Atakli, Burcu Yuksel, Pelin Dogan Ak, Hande Sariahmetoglu, Hüseyin Sari.
Abstract
Gabapentin is an antiepileptic drug approved for adjunctive therapy for partial seizures. We report a case of a patient who had thrombocytopenia with the dose of 2400 mg/day of gabapentin. The causal relationship between gabapentin and thrombocytopenia was revealed by dramatic increase in thrombocyte count following the cessation of the gabapentin treatment. To our knowledge, this is the first case report with a hematopoietic side effect of gabapentin.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26380421 DOI： 10.18071/isz.68.0270
Source DB: PubMed Journal: Ideggyogy Sz ISSN： 0019-1442 Impact factor: 0.427